258 related articles for article (PubMed ID: 36259947)
1. Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma.
Suresh S; Rabbie R; Garg M; Lumaquin D; Huang TH; Montal E; Ma Y; Cruz NM; Tang X; Nsengimana J; Newton-Bishop J; Hunter MV; Zhu Y; Chen K; de Stanchina E; Adams DJ; White RM
Cancer Discov; 2023 Jan; 13(1):194-215. PubMed ID: 36259947
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
[TBL] [Abstract][Full Text] [Related]
3. Structure and regulation of the versican promoter: the versican promoter is regulated by AP-1 and TCF transcription factors in invasive human melanoma cells.
Domenzain-Reyna C; Hernández D; Miquel-Serra L; Docampo MJ; Badenas C; Fabra A; Bassols A
J Biol Chem; 2009 May; 284(18):12306-17. PubMed ID: 19269971
[TBL] [Abstract][Full Text] [Related]
4. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
Tímár J; Gyorffy B; Rásó E
Clin Exp Metastasis; 2010 Aug; 27(6):371-87. PubMed ID: 20177751
[TBL] [Abstract][Full Text] [Related]
5. A gene expression signature of invasive potential in metastatic melanoma cells.
Jeffs AR; Glover AC; Slobbe LJ; Wang L; He S; Hazlett JA; Awasthi A; Woolley AG; Marshall ES; Joseph WR; Print CG; Baguley BC; Eccles MR
PLoS One; 2009 Dec; 4(12):e8461. PubMed ID: 20041153
[TBL] [Abstract][Full Text] [Related]
6. HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome.
Wardwell-Ozgo J; Dogruluk T; Gifford A; Zhang Y; Heffernan TP; van Doorn R; Creighton CJ; Chin L; Scott KL
Oncogene; 2014 Feb; 33(8):1017-26. PubMed ID: 23435427
[TBL] [Abstract][Full Text] [Related]
7. ZBTB7A Suppresses Melanoma Metastasis by Transcriptionally Repressing MCAM.
Liu XS; Genet MD; Haines JE; Mehanna EK; Wu S; Chen HI; Chen Y; Qureshi AA; Han J; Chen X; Fisher DE; Pandolfi PP; Yuan ZM
Mol Cancer Res; 2015 Aug; 13(8):1206-17. PubMed ID: 25995384
[TBL] [Abstract][Full Text] [Related]
8. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.
Onken MD; Worley LA; Harbour JW
Clin Cancer Res; 2008 Jun; 14(12):3737-45. PubMed ID: 18559591
[TBL] [Abstract][Full Text] [Related]
9. SATB2 induction of a neural crest mesenchyme-like program drives melanoma invasion and drug resistance.
Fazio M; van Rooijen E; Dang M; van de Hoek G; Ablain J; Mito JK; Yang S; Thomas A; Michael J; Fabo T; Modhurima R; Pessina P; Kaufman CK; Zhou Y; White RM; Zon LI
Elife; 2021 Feb; 10():. PubMed ID: 33527896
[TBL] [Abstract][Full Text] [Related]
10. A PGC1α-mediated transcriptional axis suppresses melanoma metastasis.
Luo C; Lim JH; Lee Y; Granter SR; Thomas A; Vazquez F; Widlund HR; Puigserver P
Nature; 2016 Sep; 537(7620):422-426. PubMed ID: 27580028
[TBL] [Abstract][Full Text] [Related]
11. A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis.
Hanniford D; Zhong J; Koetz L; Gaziel-Sovran A; Lackaye DJ; Shang S; Pavlick A; Shapiro R; Berman R; Darvishian F; Shao Y; Osman I; Hernando E
Clin Cancer Res; 2015 Nov; 21(21):4903-12. PubMed ID: 26089374
[TBL] [Abstract][Full Text] [Related]
12. Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases.
Xu L; Shen SS; Hoshida Y; Subramanian A; Ross K; Brunet JP; Wagner SN; Ramaswamy S; Mesirov JP; Hynes RO
Mol Cancer Res; 2008 May; 6(5):760-9. PubMed ID: 18505921
[TBL] [Abstract][Full Text] [Related]
13. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.
Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S
Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878
[TBL] [Abstract][Full Text] [Related]
14. First-in-class candidate therapeutics that target mitochondria and effectively prevent cancer cell metastasis: mitoriboscins and TPP compounds.
Ózsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2020 May; 12(11):10162-10179. PubMed ID: 32452826
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAF
Dummer R; Brase JC; Garrett J; Campbell CD; Gasal E; Squires M; Gusenleitner D; Santinami M; Atkinson V; Mandalà M; Chiarion-Sileni V; Flaherty K; Larkin J; Robert C; Kefford R; Kirkwood JM; Hauschild A; Schadendorf D; Long GV
Lancet Oncol; 2020 Mar; 21(3):358-372. PubMed ID: 32007138
[TBL] [Abstract][Full Text] [Related]
16. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition.
Deng W; Fernandez A; McLaughlin SL; Klinke DJ
J Biol Chem; 2019 Apr; 294(14):5261-5280. PubMed ID: 30723155
[TBL] [Abstract][Full Text] [Related]
17. Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b.
Chen GL; Li R; Chen XX; Wang J; Cao S; Song R; Zhao MC; Li LM; Hannemmann N; Schett G; Qian C; Bozec A
Cell Death Differ; 2021 Apr; 28(4):1364-1378. PubMed ID: 33188281
[TBL] [Abstract][Full Text] [Related]
18. An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma.
Gschaider M; Neumann F; Peters B; Lenz F; Cibena M; Goiser M; Wolf I; Wenzel J; Mauch C; Schreiner W; Wagner SN
PLoS One; 2012; 7(11):e49865. PubMed ID: 23166783
[TBL] [Abstract][Full Text] [Related]
19. The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene.
Leonard MK; Novak M; Snyder D; Snow G; Pamidimukkala N; McCorkle JR; Yang XH; Kaetzel DM
Exp Cell Res; 2019 Jan; 374(1):85-93. PubMed ID: 30458180
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.
Chatterjee A; Stockwell PA; Ahn A; Rodger EJ; Leichter AL; Eccles MR
Oncotarget; 2017 Jan; 8(4):6085-6101. PubMed ID: 28030832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
